Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate

Korean Journal of Parasitology

Volumn 46, Issue 3, 2008, Pages 145-151

  Lee, Eun Jung ^a   Heo, Yoo Mi ^a   Choi, Jong Hak ^a   Song, Hyun Ouk ^a   Ryu, Jae Sook ^a   Ahn, Myoung Hee ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Cytokine; LPS; Macrophage; NF B; Toll like receptor; Toxoplasma gondii

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOPOLYSACCHARIDE;

ARTICLE; CELL LINE; CELL STRAIN HEK293; CELL STRAIN THP 1; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE; NONHUMAN; PARASITE IMMUNITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; METABOLISM; TOXOPLASMA;

TOXOPLASMA GONDII;

ANIMALS; CELL LINE; CYTOKINES; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; TOXOPLASMA;

EID: 56149084596     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2008.46.3.145     Document Type: Article

References (29)

1. Langermans JA, Nibbering PH, Van Vuren-Van Der Halst ME, Van Furth R. Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumor necrosis factor-alpha production. Parasite Immunol 2001; 23: 169-175.
2. Lin W, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117: 1175-1183.
3. Butcher BA, Kim L, Panopoulos AD, Watowich SS, Murray PJ, Denkers EY. Cutting edge: IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages. J Immunol 2005; 174: 3148-3152.
4. Buzoni-Gatel D, Werts C. Toxoplasma gondii and subversion of the immune system. Trends Parasitol 2006; 22: 448-452.
5. Lee CW, Bennouna S, Denkers EY. Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages. Infect Immun 2006; 74: 1916-1923.
6. Belloni A, Villenu I, Gomez JE, Polloux H, Bonhomme A, Guenounoh M, Pinon JM, Aubert D. Regulation of tumor necrosis factor alpha and its specific receptors during Toxoplasma gondii infection in human monocytic cells. Parasitol Res 2003; 89: 207-213.
7. Friedland JS, Shattock RJ, Johnson JD, Remick DG, Holliman RE, Griffin GE. Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculosis. 1993; 91: 282-286.
8. Butcher BA, Kim L, Johnson PF, Denkers EY. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. J Immunol 2001; 167: 2193-2201.
9. Lang C, Gross U, Luder CG. Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 2007; 100: 191-203.
10. Aldebert D, Durand F, Mercier C, Brenier-Pinchart M, Cesbron-Delauw M, Pellowx H. Toxoplasma gondii triggers secretion of interleukin-12 but low level of interleukin-10 from the THP-1 human monocyte cell line. Cytokine 2007; 206-211.
11. Zanin-Zhorov A, Tal-Lapidot G, Cahalon L, Cohen-Sfady M, Pevsner-Fischer M, Lider O, Cohen IR. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol 2007; 179: 41-44.
12. Manson N, Aliberti J, Caamano JC, Liou H, Hunter CA. Identification of c-Rel-dependent and -independent pathways of IL-12 production during infections and inflammatory stimuli. J Immunol 2002; 168: 2590-2594.
13. Deckert-Schluter M, Buck C, Weiner D, Kaefer N, Rang A, Hof H, Wiestler OD, Schluter D. Interleukin-10 down regulates the intracerebral immune response in chronic Toxoplasma encephalitis. J Neuroimmunol 1997; 76: 167-176.
14. Belloni A, Aubert D, Gomez-Marin JE, Naour RL, Bonhomme A, Guenounou M, Pinon JM. Involvement of tumor necrosis factor-α during infection of human monocytic cells by Toxoplasma gondii. Parasitol Res 2000; 86: 406-412.
15. Buzoni-Gatel D, Werts C. Toxoplasma gondii and subversion of the immune system. Trends Parasitol 2006; 22: 448-452.
16. Zimmermann S, Murray PJ, Heeg K, Dalpke AH. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-γ signaling. J Immunol 2006; 176: 1840-1847.
17. Kim JM, Oh YK, Kim YJ, Cho SJ, Ahn MH, Cho YJ. Nuclear factor-kappa B plays a major role in the regulation of chemokine expression of HeLa cells in response to Toxoplasma gondii infection. Parasitol Res 2001; 87: 758-763.
18. Ryu JS, Kang JH, Jung SY, Shin MH, Kim JM, Park H, Min DY. Production of Interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect Immun 2004; 72: 1326-1332.
19. Akira S, Sato S. Toll-like receptors and their signaling mechanisms. Scand J Infect Dis 2003; 35: 555-562.
20. Urematsu S, Akira S. Toll-like receptor and innate immunity. J Mol Med 2006; 84: 712-725.
21. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 2004; 165: 5780-5787.
22. Yarovinsky F, Sher A. Toll-like receptor recognition of Toxoplasma gondii. Int J Parasitol 2006; 36: 255-259.
23. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, Procópio DO, Travassos LR, Smith JA, Golenbock DT, Gazzinelli RT. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001; 167: 416-423.
24. Debierre-Grockiego F, Campos MA, Azzouz N, Schmidt J, Bieker U, Resende MG, Mansur DS, Weingart R, Schmidt RR, Golenbock DT, Gazzinelli RT, Schwarz RT. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J Immunol 2007; 179: 1129-1137.
25. Mun HS, Aosai F, Norose K, Chen M, Piao L, Takeuchi O, Akira S, Ishikura H, Yano A. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 2003; 15: 1081-1087.
26. Furuta T, Kikuchi T, Akira S, Watanabe N, Yoshikawa Y. Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis. Int Immunol 2006; 18: 1655-1662.
27. Yarovinsky F, Zhang D, Ansersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hiehy S, Sutterwala FS, Flavell RA, Ghosh S, Sher A. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005; 308: 1626-1629.
28. Del Rio L, Butcher BA, Bennouna S, Hieny S, Sher A, Denkers EY. Toxoplasma gondii triggers myeloid differentiation factor 88-dependent IL-12 and chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct parasite molecules and host receptors. J Immunol 2004; 172: 6954-6960.
29. Maldonado-Bernal C, Kirschning C, Rosenstein Y, Rocha LM, Rios-Sarabia N, Espinosa-Cantellno M, Becker I, Estrada I, Salazar-Gonzalesz RM, Lopez-Macias C, Wanga H, Sanchez J, Isibasi A. The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4. Parasite Immunol 2005; 27: 127-137.